These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Humoral and cellular immunity to EBV and lymphoid cell line antigens in human lymphoma. Levine PH, Connelly RR, Herberman RB, McCoy JL, Fabrizio PL. IARC Sci Publ (1971); 1975 Sep; (11 Pt 2):225-35. PubMed ID: 191366 [Abstract] [Full Text] [Related]
5. General immunological status of nasopharyngeal carcinoma patients in Singapore. Chan SH, Goh EH, Khor TH, Chew TS. IARC Sci Publ (1971); 1978 Sep; (20):495-501. PubMed ID: 215531 [Abstract] [Full Text] [Related]
6. [Value of anti-Epstein-Barr antibody detection in the diagnosis and management of undifferentiated carcinoma of the nasopharynx]. Mazeron MC. Bull Cancer Radiother; 1996 Sep; 83(1):3-7. PubMed ID: 8679277 [Abstract] [Full Text] [Related]
7. Host responses to herpesviruses - a review. Henle W, Henle G. IARC Sci Publ (1971); 1975 Sep; (11 Pt 2):215-24. PubMed ID: 191365 [No Abstract] [Full Text] [Related]
8. Antibodies to a new antigen induced by Epstein-Barr virus in patients with nasopharyngeal carcinoma, leukemia, malignant lymphoma, and in control groups. Ida S, Sairenji T, Hinuma Y. Gan; 1972 Feb; 63(1):49-55. PubMed ID: 4339712 [No Abstract] [Full Text] [Related]
10. Epstein-Barr virus infections. Middleton PJ. Can Med Assoc J; 1974 Jan 05; 110(1):9-10. PubMed ID: 4358535 [No Abstract] [Full Text] [Related]
11. Cellular immunity in infectious mononucleosis. II. Specific reactivity to Epstein-Barr Virus antigens and correlation with clinical and hematologic parameters. Nikoskelainen J, Ablashi DV, Isenberg RA, Neel EU, Miller RG, Stevens DA. J Immunol; 1978 Oct 05; 121(4):1239-44. PubMed ID: 81224 [Abstract] [Full Text] [Related]
12. Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases. Ooka T, de Turenne-Tessier M, Stolzenberg MC. Springer Semin Immunopathol; 1991 Oct 05; 13(2):233-47. PubMed ID: 1664988 [No Abstract] [Full Text] [Related]
13. Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus. Pearson G, Dewey F, Klein G, Henle G, Henle W. J Natl Cancer Inst; 1970 Nov 05; 45(5):989-95. PubMed ID: 18605425 [Abstract] [Full Text] [Related]
14. Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus. Klein G, Dombos L, Gothoskar B. Int J Cancer; 1972 Jul 15; 10(1):44-57. PubMed ID: 4122458 [No Abstract] [Full Text] [Related]
18. Herpes viruses and oncogenesis. Klein G. Johns Hopkins Med J Suppl; 1974 Jul 15; 3():15-25. PubMed ID: 4370988 [No Abstract] [Full Text] [Related]
19. Virus-induced antigens - a review. Klein G. IARC Sci Publ (1971); 1975 Jul 15; (11 Pt 1):293-308. PubMed ID: 190131 [No Abstract] [Full Text] [Related]
20. Epstein-Barr virus gp350-specific antibody titers and antibody-dependent cellular cytotoxic effector function in different groups of patients: a study using cloned gp350-expressing transfected human T cell targets. Khyatti M, Stefanescu I, Blagdon M, Menezes J. J Infect Dis; 1994 Dec 15; 170(6):1439-47. PubMed ID: 7995983 [Abstract] [Full Text] [Related] Page: [Next] [New Search]